Yu Abe
Impact in
- Rheumatology top 2%
- Moyamoya disease diagnosis and treatment
- Neurology top 5%
- Cerebrovascular and genetic disorders
- Intracranial Aneurysms: Treatment and Complications
Papers in
-
- RNA modifications and cancer 4
- Hedgehog Signaling Pathway Studies 3
- Protein Tyrosine Phosphatases 2
- Epigenetics and DNA Methylation 2
- Genetics 5
- Genetics and Neurodevelopmental Disorders 4
- Co-authors
- Yoko Aoki (6 shared papers)Yoichi Matsubara (3 shared papers)Shigeo Kure (9 shared papers)Tetsuya Niihori (5 shared papers)Atsuo Kikuchi (10 shared papers)Shigeru Tsuchiya (4 shared papers)Yoichi Mashimo (1 shared paper)Naoto Ishii (1 shared paper)
- Journals
- Brain and Development (4 papers)Biological Psychiatry (1 paper)Journal of Hepatology (1 paper)Epilepsy Research (1 paper)Seizure (1 paper)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Yu Abe
23 papers receiving 814 citations
Yu Abe's Hit Papers
Peers
Comparison fields: 5 of 71
- Rheumatology 491
- Neurology 344
- Psychiatry and Mental health 267
- Genetics 148
- Clinical Biochemistry 29
Countries citing papers authored by Yu Abe
This map shows the geographic impact of Yu Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Abe more than expected).
Fields of papers citing papers by Yu Abe
This network shows the impact of papers produced by Yu Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Abe. The network helps show where Yu Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A genome-wide association study identifies RNF213 as the first Moyamoya disease gene Hit paper breakdown → | 2010 | 514 |
| 2 | 2012 | 63 | |
| 3 | 2016 | 45 | |
| 4 | 2011 | 28 | |
| 5 | 2011 | 26 | |
| 6 | 2017 | 25 | |
| 7 | 2018 | 19 | |
| 8 | 2014 | 12 | |
| 9 | 2015 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2010 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2013 | 8 | |
| 14 | 2001 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2013 | 7 | |
| 17 | 2009 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2022 | 3 |
About Yu Abe
Yu Abe is a scholar working on Molecular Biology, Genetics, Neurology, Rheumatology and Surgery, having authored 24 papers that have together received 825 indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (4 papers), RNA modifications and cancer (4 papers), Hedgehog Signaling Pathway Studies (3 papers), Protein Tyrosine Phosphatases (2 papers), Galectins and Cancer Biology (2 papers), Moyamoya disease diagnosis and treatment (2 papers), Epigenetics and DNA Methylation (2 papers) and Epilepsy research and treatment (2 papers). The work is most often cited by research in Rheumatology (491 citations), Neurology (344 citations), Psychiatry and Mental health (267 citations), Genetics (148 citations) and Clinical Biochemistry (29 citations). Yu Abe has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Yoko Aoki, Yoichi Matsubara, Shigeo Kure, Tetsuya Niihori, Atsuo Kikuchi, Shigeru Tsuchiya, Yoichi Mashimo, Naoto Ishii, Yuji Owada and Masao Ono. Their work appears in journals such as Brain and Development, Biological Psychiatry, Journal of Hepatology, Epilepsy Research and Seizure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.